Fundraising Fox

Savran Technologies

Newton, US · Founded 2018 · 2 known investors

savrantech.com

SavranTech is a diagnostics company developing non-invasive, cell-based diagnostic tests for women's health, starting with preeclampsia, and spanning maternal health, prenatal care, and oncology. Its patented platform serves clinicians and healthcare in the women's health diagnostics category.

BiotechDigital HealthFemTechMedical Devices

Founders & leadership

Savran Technologies was founded in 2018 by Cagri Savran.

CS
Cagri SavranFounder
NA
Nadia AltomareExecutive
YK
Yavuz KaynarExecutive
PR
Patrick RivelliNamed on SEC filing

Board

SD
Sal DaherBoard director
JB
Jeffrey BehrensBoard director
MC
Mark CarthyBoard director

Investors · 2

Reported raises · per SEC filings

Form D private placements

$6.2M disclosed across 6 rounds · 2018–2024

$424.7KraisedSep 2024 · 30 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Cagri SavranExecutive Officer, Director
  • Nadia AltomareDirector
  • Sal DaherDirector
  • Jeffrey BehrensDirector
  • Yavuz KaynarDirector
Offering amount
$2M
Amount sold
$424.7K
First sale
Aug 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$304.4KraisedMar 2023 · 18 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Cagri SavranExecutive Officer, Director
  • Sal DaherDirector
  • Jeffrey BehrensDirector
  • Nadia AltomareDirector
  • Yavuz KaynarDirector
Amount sold
$304.4K
First sale
Feb 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$4.2MraisedDec 2021 · 52 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Cagri SavranExecutive Officer, Director
  • Yavuz KaynarDirector
  • Nadia AltomareDirector
  • Sal DaherDirector
  • Jeffrey BehrensDirector
Offering amount
$4.2M
Amount sold
$4.2M
First sale
Dec 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$208KraisedMay 2020 · 11 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeff BehrensDirector
  • Simon W. TurnerExecutive Officer
  • Nadia AltomareDirector
  • Cagri SavranExecutive Officer, Director
  • Saleh DaherDirector
Offering amount
$300K
Amount sold
$208K
Minimum investment
$10K
First sale
Mar 2020
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$25KraisedFeb 2019 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Cagri SavranExecutive Officer, Director
  • Mark CarthyDirector
Offering amount
$500K
Amount sold
$25K
First sale
Sep 2018
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$1.1MraisedOct 2018 · 29 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Patrick RivelliExecutive Officer, Director
  • Mark CarthyDirector
  • Cagri SavranDirector
Offering amount
$1.1M
Amount sold
$1.1M
First sale
Jan 2018
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Savran Technologies do?
SavranTech is a diagnostics company developing non-invasive, cell-based diagnostic tests for women's health, starting with preeclampsia, and spanning maternal health, prenatal care, and oncology. Its patented platform serves clinicians and healthcare in the women's health diagnostics category.
Who founded Savran Technologies?
Savran Technologies was founded by Cagri Savran in 2018.
Who are Savran Technologies's investors?
Savran Technologies's investors include TBD Angels, Walnut Venture Associates.
How much funding has Savran Technologies raised?
Savran Technologies has disclosed $6.2M raised across 6 rounds.
Where is Savran Technologies headquartered?
Savran Technologies is headquartered in Newton, US.